DUKE UNIVERSITY
Engineering the biology of AAV secretion and production
Engineering the biology of AAV secretion and production is a funding opportunity from DUKE UNIVERSITY, up to 491773, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
ABSTRACT Recombinant adeno-associated viruses (AAV) have emerged at the forefront of gene therapy as promising vectors for treating a wide spectrum of diseases. Despite the approval of 3 different AAV gene therapy products for ocular (Luxturna), neuromuscular (Zolgensma) and metabolic (Glybera) disorders, several…